Showing results (31-40 of 54) with videos related to
Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 22, 2010
Cell-autonomous activation of the PI3-kinase pathway initiates endometrial cancer from adult uterine epitheliumSanaz Memarzadeh, Yang Zong, Deanna M Janzen, et al.Communications Biology|March 2, 2019
A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoidsNhan Phan, Jenny J Hong, Bobby Tofig, et al.Stem Cells (Dayton, Ohio)|January 24, 2013
Estrogen and progesterone together expand murine endometrial epithelial progenitor cellsDeanna M Janzen, Donghui Cheng, Amanda M Schafenacker, et al.Proceedings of the National Academy of Sciences of the United States of America|October 17, 2002
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progressionHisamitsu Ide, David B Seligson, Sanaz Memarzadeh, et al.Proceedings of the National Academy of Sciences of the United States of America|April 27, 2011
Role of autonomous androgen receptor signaling in prostate cancer initiation is dichotomous and depends on the oncogenic signalSanaz Memarzadeh, Houjian Cai, Deanna M Janzen, et al.Cancer Research|June 8, 2013
Progesterone receptor signaling in the microenvironment of endometrial cancer influences its response to hormonal therapyDeanna M Janzen, Miguel A Rosales, Daniel Y Paik, et al.Stem Cells (Dayton, Ohio)|August 23, 2012
Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiationDaniel Y Paik, Deanna M Janzen, Amanda M Schafenacker, et al.Experimental Hematology & Oncology|January 30, 2026
Stem cell engineering for the generation of allogeneic CAR-directed natural killer T cells targeting endometrial carcinomaYan-Ruide Li, Gabriella A DiBernardo, Yuning Chen, et al.Gynecologic Oncology|September 16, 2023
Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survivalLeah A Marsh, Teresa H Kim, Mingyan Zhang, et al.Molecular Cancer Therapeutics|November 14, 2013
Low levels of circulating estrogen sensitize PTEN-null endometrial tumors to PARP inhibition in vivoDeanna M Janzen, Daniel Y Paik, Miguel A Rosales, et al.Pageof 6